CNTG - Centogene raises FY2020 guidance

Centogene N.V. (CNTG) has increased FY2020 revenues guidance from €60M-€65M to greater than €80M. Richard Stoffelen, Chief Financial Officer of CENTOGENE, said, “Our core business is recovering after the significant pandemic-induced decline in Q2. In addition, we saw a significant increase in our Covid-testing revenue in recent months. We look forward to maintaining this momentum throughout the remainder of 2020, all while helping to ensure the health and safety of our team, customers, and partners around the world.”Previously: FDA OKs emergency use of Centogene coronavirus test for asymptomatic people (Oct. 19)

For further details see:

Centogene raises FY2020 guidance